Clinical screening for developmental dysplasia of the hip in Northern Ireland

S L Maxwell1, A L Ruiz, K J Lappin

  • 1Musculoskeletal Education and Research Unit, Musgrave Park Hospital, Belfast BT9 7JB. lorrainemaxwell@hotmail.com

BMJ (Clinical Research Ed.)
|April 27, 2002
PubMed

Insights

Improving screening for developmental dysplasia of the hip (DDH) significantly reduced late diagnoses. Early detection efforts are crucial, especially for infants with risk factors, to further lower surgical intervention rates.

Area of Science:

  • Orthopedics
  • Pediatric Health
  • Public Health Screening

Background:

  • High incidence of late-diagnosed developmental dysplasia of the hip (DDH) requiring surgery in Northern Ireland.
  • Previous incidence reported at 1.14 per 1000 children (1983-7).

Purpose of the Study:

  • To evaluate the impact of enhanced screening strategies on reducing late diagnoses of DDH.
  • To decrease the rate of operative intervention for DDH detected after six months of age.

Main Methods:

  • Comparative retrospective study of clinical screening programs in Northern Ireland.
  • Implementation of increased staff training, a centralized nurse-led clinic, and expanded ultrasonography use.
  • Key measure: Reduction in operative interventions for DDH diagnosed after six months.

Main Results:

  • Incidence of DDH diagnosed after six months decreased to 0.59 per 1000 children (1991-7).
  • Despite improvements, 16% of affected hips were not diagnosed at initial referral (first 3 months).
  • 27 affected hips (diagnosed after six months) had known risk factors like family history or breech delivery.

Conclusions:

  • Enhanced screening processes demonstrably reduce the late incidence of DDH.
  • Further improvements in detecting DDH in infants with risk factors and at initial referral are needed to minimize late presentations.
Abstract

Related Concept Videos